Drugs / Premixed bioceramic MTA
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06219824 | Nov 2024 → Nov 2025 overdue | dental caries, dental pulp disorder | Cairo University | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT05928858 | Sep 2023 → Jun 2024 | dental pulp calcification | Cairo University | Unknown | No outcome recorded |
| Phase 3 | NCT05314842 | Apr 2022 → Apr 2023 | dental caries | Sarah Abdelbar Mahmoud | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Premixed bioceramic MTA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05314842 ↗ |
| Modality | Other / unclassified | “premixed ready for use bioceramic MTA” NCT06219824 ↗ |